Evidence map›Paper›PMID 41626548›Full record

ReviewInnovation (Cambridge (Mass.))2025

Stories behind drug discovery: Key figures, cutting-edge technologies, and blockbuster drugs.

Bingjie Li, Yequn Chen, Linlin Shi, Erik De Clercq, Peng Zhan, Bin Yu

Abstract readReview
In one paragraph

Review in Innovation (Cambridge (Mass.)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bingjie LiDepartment of Cardiology, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
Yequn ChenDepartment of Cardiology, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
Linlin ShiDepartment of Cardiology, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
Erik De ClercqLaboratory of Virology and Chemotherapy, Rega Institute for Medical Research, 3000 Leuven, Belgium.
Peng ZhanKey Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Bin YuState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, State Key Laboratory of Antiviral Drugs, Tianjian Laboratory of Advanced Biomedical Sciences, Pingyuan Laboratory, College of Chemistry, Zhengzhou University, Zhengzhou 450001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41626548
PMCPMC12859659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.